Anti-CDH17 CAR-T cell therapy

CDH17-targeted chimeric antigen receptor T-cell · Shanghai Pudong Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anti-CDH17 CAR-T cell therapy, covering 2024-07-15 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors [EARLY_Phase 1]

See pricing